Bioinformatics inspiring peptides from toxins as a new alternative in obesity treatment
DOI:
https://doi.org/10.33448/rsd-v10i14.22057Keywords:
animal venom, bioinspired peptides, rational design, inflammation, obesity.; Animal venom; Bioinspired peptides; Rational design; Inflammation; Obesity.Abstract
Obesity is a nutritional disorder caused by the excessive accumulation of white adipose tissue (WAT) in the body, which is characterized by a high body mass index and interferes with the body's energy balance. Obesity is a major risk factor for a number of different diseases, such as type 2 diabetes, cardiovascular disease, hypertension, fatty liver disease and some malignant tumors. The treatment of obesity primarily focuses on diet and physical exercise; when lifestyle changes fail, drugs and surgery will be considered as treatment options. At present, a number of so‑called anti‑obesity drugs have been developed, which affect digestion and absorption. These drugs can produce significant weight loss in the individual; however, some patients are unwilling to receive this type of treatment, due to side effects such as insomnia, hypertension and dizziness. This perspective shows that rational design is an alternative methodology based on native bioactive molecules for the development of analogous compounds, improved from the point of view of efficiency and side effects. We also show that the modification of peptides from animal toxins can be an interesting alternative in the treatment of obesity, since peptides from toxins have already shown significant anti-inflammatory effects.
References
Ahmed, B., Sultana, R., & Greene, M. W. (2021). Adipose tissue and insulin resistance in obese. Biomedicine & Pharmacotherapy, 137, 111315. 10.1016/j.biopha.2021.111315
Al-Goblan, A. S., Al-Alfi, M. A., & Khan, M. Z. (2014). Mechanism linking diabetes mellitus and obesity. Diabetes, metabolic syndrome and obesity: targets and therapy, 7, 587. 10.2147/DMSO.S67400
Fosgerau, K., & Hoffmann, T. (2015). Peptide therapeutics: current status and future directions. Drug discovery today, 20(1), 122-128. 10.1016/j.drudis.2014.10.003
Friedman, J. (2016). The long road to leptin. The Journal of clinical investigation, 126(12), 4727-4734. 10.1172/JCI91578
Gao, Y., Yuan, X., Zhu, Z., Wang, D., Liu, Q., & Gu, W. (2020). Research and prospect of peptides for use in obesity treatment. Experimental and Therapeutic Medicine, 20(6), 1-1. 10.3892/etm.2020.9364
Hochberg, A., Patz, M., Karrasch, T., Schäffler, A., & Schmid, A. (2021). Serum levels and adipose tissue gene expression of cathelicidin antimicrobial peptide (CAMP) in obesity and during weight loss. Hormone and Metabolic Research, 53(03), 169-177. 10.1055/a-1323-3050
Irazazabal, L. N. (2016). Avaliação estrutural e funcional de novos peptídeos antimicrobianos obtidos a partir de desenho racional (Doctoral dissertation, Université Pierre et Marie Curie-Paris VI).
Kelly, A. S., Rudser, K. D., Nathan, B. M., Fox, C. K., Metzig, A. M., Coombes, B. J., & Abuzzahab, M. J. (2013). The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial. JAMA pediatrics, 167(4), 355-360. 10.1001/jamapediatrics.2013.1045
Lopes, J. F., Matos, M. A., Magalhães, F. C., Esteves, E. A., Vieira, E. R., & Amorim, F. T. (2017). Efeito de mudanças graduais de exercício físico e dieta sobre a composição corporal de obesos. Arquivos de Ciências da Saúde, 24(1), 93-97. 10.17696/2318-3691.24.1.2017.442
Migliolo, L., Felício, M. R., Cardoso, M. H., Silva, O. N., Xavier, M. A. E., Nolasco, D. O., & Franco, O. L. (2016). Structural and functional evaluation of the palindromic alanine-rich antimicrobial peptide Pa-MAP2. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1858(7), 1488-1498. 10.1016/j.bbamem.2016.04.003
Moreno, M., & Giralt, E. (2015). Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan. Toxins, 7(4), 1126-1150. 10.3390/toxins7041126
Schütz, F., Figueiredo-Braga, M., Barata, P., & Cruz-Martins, N. (2021). Obesity and gut microbiome: review of potential role of probiotics. Porto Biomedical Journal, 6(1). 10.1097/j.pbj.0000000000000111
Srivastava, G., & Apovian, C. (2018). Future pharmacotherapy for obesity: new anti-obesity drugs on the horizon. Current obesity reports, 7(2), 147-161.
Vancea, D. M. M. (2019). A influência do exercÃcio fÃsico e suas variá veis sobre os marcadores inflamatórios em adultos obesos: uma revisã o sistemá tica. RBPFEX-Revista Brasileira de Prescrição e Fisiologia do Exercício, 13(85), 852-861.
Wei, L., Yang, J., He, X., Mo, G., Hong, J., Yan, X., & Lai, R. (2013). Structure and function of a potent lipopolysaccharide-binding antimicrobial and anti-inflammatory peptide. Journal of Medicinal Chemistry, 56(9), 3546-3556. 10.1021/jm4004158
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ana Paula de Aráujo Boleti; Thiago Antonio Almeida Rodrigues; Maria Eduarda Freitas Biembengute; Lincoln Takashi Hota Mukoyama; Ludovico Migliolo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
